Current cancer nanomedicines can only mitigate adverse effects but fail to enhance
therapeutic efficacies of anticancer drugs. Rational design of next‐generation cancer …

The development of biodegradable polymers represents a revolution in medicine spanning
over 50 years and leading to significant biotechnological advancements in drug delivery …

The use of nanoparticulate pharmaceutical drug delivery systems (NDDSs) to enhance the
in vivo effectiveness of drugs is now well established. The development of multifunctional …

To date, numerous inorganic nanocarriers have been explored for drug delivery systems
(DDSs). However, the clinical application of inorganic formulations has often been hindered …

In the past decades, polymeric nanoparticles have emerged as a most promising and viable
technology platform for targeted and controlled drug delivery. As vehicles, ideal …

The last decade has witnessed enormous research focused on cationic polymers. Cationic
polymers are the subject of intense research as non-viral gene delivery systems, due to their …

In this review, we outline examples that illustrate the design criteria for achieving
macromolecular assemblies that incorporate a combination of two or more chemical …

Driven by the urgent need in practical applications of stimuli-responsive nano-carriers for
intracellular drug delivery, the design and development of advanced polymeric micelles …

Biomaterial central infection (BCI) is a tough problem that has attracted high attention. The
most common source of infection in biomaterial centers is bacterial infections. For the past …

Redox and pH dual-responsive biodegradable micelles were developed based on poly
(ethylene glycol)-SS-poly (2, 4, 6-trimethoxybenzylidene-pentaerythritol carbonate)(PEG-SS …